New Osteoporosis Guidelines Issued for Postmenopausal Women

More postmenopausal women could benefit from medications to treat osteoporosis despite the potential risks of some medications, according to the authors of the new guidelines released March 25, 2019, at ENDO, the annual meeting of the Endocrine Societyin New Orleans.

The document, which took five years to prepare and the first new guidance on osteoporosis in this age group in more than a decade, is also underway. Posted in the May 2019 issue of Journal of Endocrinology and Metabolism.

The guidelines address what doctors say are worrisome trends in screening and treatment for osteoporosis, which is believed to affect 54 million American adults, most of them postmenopausal women.

Related: 4 health risks faced by women after menopause

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button